2021 annual financial data

Estrella Immunopharma 2021 Operating margin

Direct answer

Operating margin was Not calculable.

Operating income was -1.69M USD and net income was -1.69M USD.
Operating cash flow was -1.44M USD.

Get free Estrella Immunopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-1.69M USD
Net income
-1.69M USD
Operating cash flow
-1.44M USD